What is Bergeson & Campbell?
Bergeson & Campbell PC operates as a highly specialized legal practice, providing essential counsel within the intricate regulatory frameworks governing chemical products. The firm distinguishes itself through deep technical expertise in conventional, biobased, and nanoscale formulations. By offering comprehensive guidance on compliance with the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and the Food Quality Protection Act, the firm serves as a vital partner for companies managing high-stakes product approvals. Their practice is uniquely structured to bridge the gap between technical chemical data and federal agency requirements, ensuring that clients successfully navigate the submission processes for FDA and other regulatory bodies. Beyond advisory services, the firm provides robust litigation support and business counseling, addressing both transactional needs and contentious regulatory disputes.
How much funding has Bergeson & Campbell raised?
Bergeson & Campbell has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Bergeson & Campbell
PPP
Public-Private Partnership
What's next for Bergeson & Campbell?
The recent capital injection signals a strategic pivot toward scaling the firm's advisory capacity in response to evolving global chemical safety standards. As regulatory scrutiny intensifies, particularly regarding nanoscale and biobased materials, Bergeson & Campbell is expected to leverage this financing to enhance its data compensation arbitration practice and litigation support capabilities. By deepening its bench of technical legal experts, the firm aims to maintain its competitive edge in providing high-authority counsel for companies facing complex compliance challenges. This growth trajectory suggests a focus on long-term sustainability and the expansion of its footprint in the specialized legal services market, ensuring that clients remain compliant while navigating the shifting landscape of federal chemical oversight.
See full Bergeson & Campbell company page
